Calcitonin Estimation in Neck Lymph Node Fine-Needle Aspirate Fluid Prevents Misinterpretation of Cytology in Patients with Metastatic Medullary Thyroid Cancer
Restricted accessLetterFirst published online September, 2009
Calcitonin Estimation in Neck Lymph Node Fine-Needle Aspirate Fluid Prevents Misinterpretation of Cytology in Patients with Metastatic Medullary Thyroid Cancer
OrlandiF, CaraciP, MussaA, SaggioratoE, PancaniG, AngeliA. 2001. Treatment of medullary thyroid carcinoma: an update. Endocr Relat Cancer, 8:135–147.
2.
KebebewE, ItuartePH, SipersteinAE, DuhQY, ClarkOH. 2000. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer, 88:1139–1148.
3.
SuttonRT, ReadingCC, CharboneauJW, JamesEM, GrantCS, HayID. 1988. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology, 168:769–772.
4.
EsikO, SzavcsurP, SzakállSJr, BajzikG, RepaI, DabasiG, FüzyM, SzentirmayZ, PernerF, KáslerM, LengyelZ, TrónL. 2001. Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma. Cancer, 91:2084–2095.
5.
de GrootJW, LinksTP, JagerPL, KahramanT, PlukkerJT. 2004. Impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol, 11:786–794.
6.
IsaevPA, MedvedevVS, Il'inAA, RumiantsevPO, ChebotarevaIV, Terent'evPO, AbrosimovAlu, VtiurinBM, ParshkovEM, SeverskaiaNV, MarchenkoEV. 2004. Assay of thyrocalcitonin in cervical lymph node using fine-needle washings for the diagnosis of disseminated medullary thyroid carcinoma. Vopr Onkol, 50:46–49. (In Russian.)
7.
BoiF, MaurelliI, PinnaG, AtzeniF, PigaM, LaiML, MariottiS. 2007. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab, 92:2115–2118.
8.
KebebewE, KikuchiS, DuhQY, ClarkOH. 2000. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg, 135:895–901.
